Patents Assigned to Luminescent MD, LLC
  • Patent number: 10040992
    Abstract: Chemiluminesescence is emitted from a reaction between phenylglyoxal derivatives and guanine. This chemiluminescence can be used in CRET for the detection of one or more analytes of interest. Chemical pathways depicting the chemiluminescent reaction and intermediates produced therein are shown, as are novel nanoparticles for use in the present methods and compositions.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: August 7, 2018
    Assignee: LUMINESCENT MD, LLC
    Inventors: Ji Hoon Lee, Sandy Cho
  • Publication number: 20160115381
    Abstract: Chemiluminesescence is emitted from a reaction between phenylglyoxal derivatives and guanine. This chemiluminescence can be used in CRET for the detection of one or more analytes of interest. Chemical pathways depicting the chemiluminescent reaction and intermediates produced therein are shown, as are novel nanoparticles for use in the present methods and compositions.
    Type: Application
    Filed: May 9, 2014
    Publication date: April 28, 2016
    Applicant: LUMINESCENT MD, LLC
    Inventors: Ji Hoon LEE, Sandy CHO
  • Publication number: 20150301036
    Abstract: Additives capable of controlling the reaction rate between substrate and enzyme to form a dye in enzyme assays with absorbance, chemiluminescence, and fluorescence are effective tools for optimizing enzyme assays. A dye can be formed rapidly from the reaction between enzyme and substrate in the presence of a catalyst. Using relatively high concentration of dye formed from the rapid reaction, trace levels of analytical materials can be quantified using absorbance, chemiluminecence and fluorescence detection. A dye can be formed from a relatively slow reaction between enzyme and substrate in the presence of a surfactant such as TritonĀ® X-100 and ?-cyclodextrin. Using relatively low concentration of dye from the slow reaction, a high concentration of analytical material can be quantified without any dilution using absorbance, chemiluminescence, and fluorescence.
    Type: Application
    Filed: December 24, 2014
    Publication date: October 22, 2015
    Applicant: LUMINESCENT MD, LLC
    Inventor: Ji Hoon LEE
  • Publication number: 20150276725
    Abstract: A chemiluminescent immunoassay for sensing an analyte in a sample includes an oligonucleotide, a buffer solution, a chemiluminescent reagent, and a micro-particle or a nano-particle. An analyte in a sample is detected by conjugating an oligonucleotide with (i) a fluorescent dye or a fluorescent polystyrene bead and (ii) a micro-particle or a nano-particle; mixing the conjugated oligonucleotide and a chemiluminescent reagent; and measuring light intensity generated as a result of mixing the conjugated oligonucleotide and chemiluminescent reagent. The oligonucleotide advantageously captures and detects the analyte without the requirement of an anti-body. The micro-particle or nano-particle removes excess oligonucleotide without the requirement of washing.
    Type: Application
    Filed: October 10, 2013
    Publication date: October 1, 2015
    Applicant: LUMINESCENT MD, LLC
    Inventor: Ji Hoon Lee
  • Patent number: 9017950
    Abstract: Additives capable of controlling the reaction rate between substrate and enzyme to form a dye in enzyme assays with absorbance, chemiluminescence, and fluorescence are effective tools for optimizing enzyme assays. A dye can be formed rapidly from the reaction between enzyme and substrate in the presence of a catalyst. Using relatively high concentration of dye formed from the rapid reaction, trace levels of analytical materials can be quantified using absorbance, chemiluminecence and fluorescence detection. A dye can be formed from a relatively slow reaction between enzyme and substrate in the presence of a surfactant such as Triton X-100 and ?-cyclodextrin. Using relatively low concentration of dye from the slow reaction, a high concentration of analytical material can be quantified without any dilution using absorbance, chemiluminescence, and fluorescence.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: April 28, 2015
    Assignee: Luminescent MD, LLC
    Inventor: Ji Hoon Lee
  • Publication number: 20130288270
    Abstract: A chemiluminescent enzyme immunoassay method for quantifying antigen or antibody using 1,1?-oxalyldiimidazole (ODI) derivative or 1,1?-oxalyldisodium benzoate (ODB) derivative chemiluminescence (CL) detection was developed. Also, various enzymes were quantified using ODI derivative or DOB derivative CL detection. Fluorescent compound formed from a substrate (non-fluorescent compound) through the enzyme assay methods emitted CL when the fluorescent compound received energy from high-energy intermediate formed in ODI derivative or ODB derivative CL reaction.
    Type: Application
    Filed: June 26, 2013
    Publication date: October 31, 2013
    Applicant: LUMINESCENT MD. LLC
    Inventor: Ji Hoon Lee, SR.
  • Patent number: 8492101
    Abstract: A chemiluminescent enzyme immunoassay method for quantifying antigen or antibody using 1,1?-oxalyldiimidazole (ODI) derivative or 1,1?-oxalyldisodium benzoate (ODB) derivative chemiluminescence (CL) detection was developed. Also, various enzymes were quantified using ODI derivative or DOB derivative CL detection. Fluorescent compound formed from a substrate (non-fluorescent compound) through the enzyme assay methods emitted CL when the fluorescent compound received energy from high-energy intermediate formed in ODI derivative or ODB derivative CL reaction.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: July 23, 2013
    Assignee: Luminescent MD, LLC
    Inventor: Ji Hoon Lee